The spectrum of HIV-associated neurocognitive disorder (HAND) has been dramatically
altered in the setting of widely available effective antiretroviral therapy (ART). Once …

Background: Over the past three decades, the clinical presentation of HIV infection of the
Central Nervous System (CNS) has evolved. Prior to wide spread use of effective …

Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) affects
roughly half the HIV-positive population. The symptoms of cognitive slowing, poor …

In the era of highly active antiretroviral therapy (HAART), HIV-1-associated neurocognitive
disorder (HAND) continues to be a common and significant morbidity among individuals …

The neurocognitive disorders associated with HIV (HAND) remain among the most common
clinical disorders encountered in people infected with HIV, even in an era in which potent …

Neurocognitive impairments following central nervous system opportunistic infections and
HIV-associated dementia (HAD) were common clinical features of HIV infection prior to anti …

Thirty years into the HIV epidemic, the management and investigation of neurologic
complications of HIV disease have evolved from a struggle to understand and treat …

The effects of HIV-1 in the nervous system are a topic of avid interest to investigators and
clinicians focused on HIV, judging by the large and discriminating audience at the oral …

Objective: To determine whether cognitive impairment and brain injury as measured by
proton magnetic resonance spectroscopy (MRS) persist in the setting of HAART. Design …

Background. The human immunodeficiency virus (HIV) can give rise to a spectrum of
neuropsychological impairments known collectively as HIV-associated neurocognitive …